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Quantitative proteomics is challenging and various stable isotope based approaches have been
developed to meet the challenge. Hereby we describe a simple, efficient, reliable, and
inexpensive method named reductive alkylation by acetone (RABA) to introduce stable
isotopes to peptides for quantitative analysis. The RABA method leads to alkylation of
N-terminal and lysine amino groups with isopropyl moiety. Using unlabeled (d0) and
deuterium labeled (d6) acetone, a 6 Da mass split is introduced to each isopropyl modification
between the light and heavy isotope labeled peptides, which is ideally suited for quantitative
analysis. The reaction specificity, stoichiometry, labeling efficiency, and linear range of the
RABA method have been thoroughly evaluated in this study using standard peptides, tryptic
digest of proteins, as well as human cell lysate. Reliable quantitative results have been
consistently obtained in all experiments. We also applied the RABA method to quantitative
analysis of proteins in spinal cords of transgenic mouse models of amyotrophic lateral
sclerosis. Highly homologous proteins (transgenic human SOD1 and endogenous mouse
SOD1) were distinguished and quantified using the method developed in this study. In
addition, the quantitative results using the RABA approach were independently validated by
Western blot. (J Am Soc Mass Spectrom 2009, 20, 1366–1377) © 2009 American Society for
Mass SpectrometryQuantitative analysis of protein expression levelsis a critical issue in proteomics. Mass spectrom-
etry (MS) has become one of the most powerful
tools in proteomic analysis in the past decade [1].
Several MS-based methods have been developed for
quantitative proteomics analysis [2–6]. In particular,
stable isotope labeling approaches that generate pairs of
light and heavy isotopic peaks with several Da mass
difference have been widely used. These methods are
based on the generation of two pools of protein/
peptide samples—one with naturally occurring iso-
topes (light) and the other with enriched heavy isotopes
such as deuterium 2D, 13C, 15N or 18O. Equal quantities
of these two samples are pooled and subjected to the
same preparation and analysis procedures. The light
and heavy isotopic peaks are resolved in mass spec-
trometry and their relative abundances are calculated to
represent the relative quantification of the correspond-
ing protein in the starting samples.
Stable isotopes can be incorporated into proteins
either in vivo during cell growth or in vitro after cell
lysis. The examples of in vivo labeling include universal
15N labeling [4, 7–9] and amino acid specific labeling [5,
10–13]. However, these methods are limited to cultured
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doi:10.1016/j.jasms.2009.03.027cells and cannot be extended to studying animal or
patient tissues. The in vitro stable isotope labeling
approaches introduce various isotopic tags through
chemical reactions with proteins/peptides and usually
target specific amino acid residues such as cysteine and
lysine, N-terminal or C-terminal residues of tryptic
peptides [14–23]. An elegant example is the design of
an isotope-coded affinity tag (ICAT) that contains a
thiol-reactive group that reacts with cysteine residues, a
polyether linker that can be labeled with deuterium,
and an affinity tag, e.g. biotin, that allows the rapid
purification of the cysteine-containing peptides [3].
However, the ICAT approach cannot analyze peptides
lacking a cysteine residue. Acylation of N-terminus and
-amino groups of lysine residues by acetic anhydride
or N-acetoxysuccinimide has also been reported [24–
26]. However, acylation of basic amine groups changes
the ionic states of peptides and may reduce the ioniza-
tion efficiency of peptides. Alternatively, 18O can be
introduced to the C-terminus of tryptic peptides during
protein hydrolysis by trypsin [27, 28]. More recently,
iTRAQ reagents, a new family of isobaric multiplex
tagging derivates, have been introduced for 4-plex
[29–33] and 8-plex [34, 35] quantitative proteomic anal-
ysis. The iTRAQ reagents are amine-specific and react
with N-terminus and lysine residues of the trypsin
digested peptides. A particular peptide from up to four
samples yields the same mass value after being modi-
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the modified peptide yields four different reporter ions
in the MS/MS mode, representing the relative abun-
dances of this peptide in the four starting samples.
We here describe a simple and cost-effective method
using acetone to modify amine groups at both N-
terminus and lysine residues based on a well estab-
lished reductive alkylation reaction [36, 37]. The reduc-
tive alkylation by acetone (RABA) reaction can be
utilized to modify peptides stoichiometrically with over
99% yield in 30 min with high specificity toward
primary amine groups. Using unlabeled (d0-acetone)
and deuterium labeled acetone (d6-acetone), this me-
thod introduces 6 Da mass split for each isopropyl
modification between the light and heavy isotope la-
beled peptides, which can avoid the naturally occurring
isotope envelops and thus is ideally suited for quanti-
tative analysis. The application of this reaction to quan-
titative analysis is demonstrated and evaluated using
standard peptides, tryptic peptides from proteins as
well as human cell lysate and transgenic mouse tissue
homogenate in this study. The results support that the
RABA method can be used to achieve reliable quantifi-
cation of proteins levels in complex samples. The ad-
vantages of the RABA approach include the ready
availability of the inexpensive reagents, the relative
simplicity of the reaction, and the high yield to produce
labeled peptides in 2 hours.
Experimental
Materials
Acetone, acetone-d6 (cat no. 540331, 99.9 atom % deu-
terium), sodium cyanoborohydride (NaBH3CN), dithio-
threitol (DTT), iodoacetamide (IAA), formic acid, triflu-
oroacetic acid (TFA), angiotensin II, horse cytochrome c,
horse myoglobin, bovine serum albumin (BSA), and
-cyano-4-hydroxycinnamic acid (CHCA) were pur-
chased from Sigma-Aldrich (St. Louis, MO). Trypsin
was obtained from Promega (Madison, WI). HPLC
grade acetonitrile and water were obtained from Fisher
Scientific (Hampton, NJ). Strong cation exchange bead
(POROS 20 HS) was from Applied Biosystems (Foster
City, CA).
Cell Culture and Animal Methods
Human embryonic kidney cell line (HEK293) was cul-
tured at 37 °C under 5% CO2-95% air in Dulbecco’s
modified Eagle’s medium (DMEM, Gibco) containing
10% fetal bovine serum, 100 units/mL penicillin, and
100 g/mL streptomycin. Cells were harvested after
reaching 90% confluence. Cell lysate was prepared as
previously described [38] and served as a complex
background in testing the quantitative approach in this
study.
Transgenic mice strains overexpressing WT and G93A
mutant SOD1, which are the animal models for studyingamyotrophic lateral sclerosis (ALS, Lou Gehrig’s disease),
were maintained as hemizygotes at the University of
Kentucky animal facility. G93A SOD1 transgenicmice and
age-matchedWT SOD1 transgenic mice were sacrificed at
age of 90 d. Mice were anesthetized with an intraperito-
neal injection of 0.3 mL of pentobarbital (50 mg/mL;
Abbott Laboratories, Abbott Park, IL) and transcardically
perfused with 0.1 M PBS, pH 7.5. Spinal cords were
dissected as previously described [39] and subjected to
quantitative analysis using the approach developed in this
study. All animal procedures were approved by each
university’s IACUC committee.
RABA Reaction of Peptides
Standard proteins, BSA, myoglobin, and cytochrome c,
were dissolved in 25 mM NH4HCO3 and digested
overnight at 37 °C with trypsin without performing
DTT reduction. The stock solutions of the tryptic
peptides of BSA, myoglobin and cytochrome c were
at concentrations of 13.4, 49.0, and 55.6 pmol/L,
respectively, based on the amount of proteins used
for digestion.
Peptides, both standard peptide (angiotensin II) and
tryptic peptides of proteins, were dissolved in 90%
acetonitrile containing 0.1% formic acid at indicated
concentrations. The reducing reagent NaBH3CN was
freshly prepared before use each time in unlabeled
(d0-acetone) or deuterated acetone (d6-acetone) at the
concentration of 36 g/L. The RABA reaction was
performed by mixing 20 L peptide solution and 5 L
acetone containing 36 g/L NaBH3CN at room-
temperature for 30 min or indicated periods of time. The
reaction mixture was dried using a SpeedVac (Thermo,
Holbrook, NY) and the reaction stopped after acetone
evaporated. The sample was reconstituted in 20 L 90%
acetonitrile containing 0.1% formic acid and subjected
to mass spectrometric analysis. The mock reaction con-
trol was carried out in the same fashion except using
acetone without the reducing reagent NaBH3CN, in
which the RABA reaction did not occur.
Different periods of reaction time were tested and
the reaction yield over the time course of the RABA
reaction was determined. Different quantities of pep-
tides were used as starting material in the RABA
reaction to evaluate the sensitivity of the reaction.
Quantitative Analysis Using RABA Reaction
with Peptides
Peptides were reacted with unlabeled (d0-acetone) or
deuterated acetone (d6-acetone) separately, subsequen-
tly mixed, and subjected to mass spectrometric analysis.
Different quantities of peptides were used in each
reaction and the ratio of the quantities of peptides used
in the d0- and d6-acetone RABA reaction was defined as
the expected ratio. The experimental ratio was calcu-
lated based on the ratio of the centroid intensities of the
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were derived from d0- and d6-acetone, respectively). In
the direct infusion experiments, MS spectra were ob-
tained by averaging the spectra acquired over one
minute and the centroid intensities of the light and
heavy isotopic peaks in the average MS spectra were
used for calculating ratios. In the nano-LC-MS/MS
experiments, MS spectra were averaged over peak
elution of each peptide of interest.
The dynamic range of the method was first tested by
quantifying angiotensin II mixed at various expected
ratios (d0:d6 from 1:20 to 20:1). Furthermore, myoglobin,
cytochrome c and BSA tryptic digestion samples were
mixed with various expected ratios. The ratios of the
proteins were experimentally determined by subjecting
the tryptic peptides to the d0- or d6-acetone RABA
reaction, mixing the two reaction samples, analyzing
the reaction mixture by mass spectrometry, and calcu-
lating the ratio of the light and heavy isotopic peaks of
the d0- and d6-isopropyl products. The experimentally
measured ratios were compared to the expected ratios
of the protein mixtures to demonstrate the accuracy of
this approach.
RABA Reaction of Tryptic Peptides in the
Background of Human Cell Lysate
We then tested whether this approach is able to distin-
guish protein abundance changes in the background of
complex mixture. More complex samples were pre-
pared by spiking standard proteins to the HEK293 cell
lysate. Sample A contained 120 g HEK293 cell lysate
and a total of 2 g of BSA, myoglobin and cytochrome
c (0.8 g BSA, 0.6 g myoglobin and 0.6 g cytochrome
c). Samples B, C, and D contained 120 g HEK293 cell
lysate and 2, 4, and 10 g of BSA, myoglobin and
cytochrome c, respectively. All samples were subjected
to dithiothreitol (DTT) reduction, iodoacetamide (IAA)
alkylation, and trypsin digestion in solution over night.
Three pairs of comparison samples were generated
using the above tryptic peptides: B:A, C:A, and D:A.
Each pair of samples was subjected to RABA reaction
using d0- and d6- acetone for 2 h at room temperature as
described earlier. The reaction was quenched by adding
10 L 1M glycine (final concentration of 0.25 M). Equal
amount of d0- and d6-modified peptides were mixed
and subjected to nano-LC-MS/MS analysis as described
below. The ratios of BSA, myoglobin and cytochrome c
in the three pairs of samples were determined by
calculating the ratio of the light and heavy isotopic
peaks of the d0- and d6-isopropyl products over the
peak elution of the corresponding peptide. The experi-
mentally measured ratios were compared to the ex-
pected ratios of the protein mixtures to demonstrate the
accuracy of this approach in the complex background of
human cell lysate.RABA Reaction of Tryptic Peptides Derived from
Transgenic Mouse Tissues
Dissected mouse spinal cords were lysed in radioim-
mune precipitation assay (RIPA) buffer (50 mM Tris-
HCl pH 7.4, 1% Nonidet P-40, 0.25% sodium deoxy-
cholate, 150 mM NaCl, 1 mM EDTA) as previously
described [39]. Protein concentrations were determined
by Bradford assay (BioRad, Hercules, CA) and equal
amount of protein from wild type and mutant SOD1
mice spinal cord was precipitated by trichloroacetic
acid (TCA). The proteins were re-dissolved in 25 mM
ammonia bicarbonate containing 0.2% SDS, then sub-
jected to DTT reduction, IAA alkylation, and trypsin
in-solution digestion over night. The resulting tryptic
peptides from wild-type and G93A mouse spinal cords
were labeled by RABA reaction with d0- and d6-acetone,
respectively. The RABA reaction was quenched by 1M
glycine after 2 h reaction at room-temperature. The
equal amount of d0- and d6-isopropyl modified pep-
tides were mixed and then fractionated by strong cation
exchange beads using step gradient containing 50%
ACN, 0.1% formic acid, and varying concentrations of
ammonium acetate from 0 to 200 mM. A total of 9
fractions (unbound supernatant, and fractions eluted
with 0, 20, 40, 60, 80, 100, 150, 200 mM ammonium
acetate) were collected. Each fraction was concentrated
from 200 to 20 L, and 5 L of each fraction were
subjected to reverse phase LC-MS/MS analysis.
The LC-MS/MS data were submitted to a local
MASCOT server for MS/MS protein identification
search using “merged search” function of Mascot Dae-
mon. The MS/MS data from nine ion-exchange frac-
tions were combined to perform a single merged search.
The typical parameters were: Mammal for standard
proteins, Homo sapiens for HEK293 cell lysate, and
Mus for mouse spinal cord homogenate, Sprot database
(51.0), maximum of three trypsin missed cleavages,
cysteine carbamidomethylation, methionine oxidation,
d0-isopropyl, d6-isopropyl, 100 ppmMS error tolerance,
and 0.5 Da MS/MS error tolerance. The search was
mainly utilized to identify the d0- or d6-isopropyl
modified peptides in this study. The ratio of the inten-
sities of the light and heavy isotopic peaks of each
tryptic peptide was calculated over the peak elution of
the corresponding peptide. The ratios of several tryptic
peptides from the same protein were averaged as the
experimentally determined quantitative results of the
protein.
Mass Spectrometry
The reductive alkylation reaction products were ana-
lyzed by both electrospray (ESI) MS/MS and MALDI-
TOF-TOF mass spectrometry. The ESI MS/MS data
were collected from a Q-Star XL quadrupole time-of-
flight mass spectrometer (ABI/MDS SCIEX, Foster City,
CA) using either direct infusion or a nano-flow HPLC
system (Eksigent, Dublin, CA). For direct infusion
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acetonitrile containing 0.1% formic acid and loaded to
Au/Pd-coated spray emitter (Proxeon, Odense, Den-
mark). The electrospray voltage was 2100 V and the
mass range of TOF MS was from 350 to 1600 (m/z).
Nano-flow LC-MS/MS was done by exploiting the
nano-HPLC system for sample pick-up and separation,
where desired volume of sample solution was injected
by autosampler and desalted on a trap column (LC
Packings 300 m i.d.  5 mm), and was subsequently
separated by reverse phase C18 column (Vydac 75 m
i.d.  150 mm) at a flow rate of 200 nL/min. The HPLC
gradient was linear from 5 to 75% B in 55 min using
mobile phase A (H2O, 0.1% formic acid) and B (80%
acetonitrile, 0.1% formic acid). Data acquisition was
done using information-dependent mode, each cycle
typically consisted of a 1s TOF MS survey from 350 to
1600 (m/z) and two 2s MS/MS scans with mass range of
100–1600 (m/z).
MALDI-TOF-TOF mass spectrometry was per-
formed using a 4800 Plus analyzer (ABI/MDS SCIEX,
Foster City, CA) equipped with a 355 nm N2 laser (200
Hz). Matrix was prepared by dissolving CHCA in 50%
acetonitrile, 0.1% TFA at a concentration of 1 g/L.
Samples were diluted 20 before spotting, mixed with
the matrix 1:1 and air-dried. The MALDI-TOF spectra
were acquired with 400 laser shots.
Western Blotting
Selected proteins in the mouse spinal cord experiment
were subjected to Western blotting analysis for inde-
pendent confirmation of the quantitative results ob-
tained by the RABA approach. Briefly, 15–25 g of wild
type and G93A mice spinal cord protein were subjected
to 15% SDS-PAGE gels and transferred onto nitrocellu-
lose membranes. Membranes were blocked in 5% milk
or 3% BSA in TBST (100 mM Tris-buffered saline, pH
7.4, 0.15% Tween-20) for 1 h at room temperature,
followed by incubation with the indicated primary
antibodies in TBST for 5 h at room temperature. After
three washes with TBST membranes were incubated
with the indicated secondary antibodies for 1 h at room
temperature. After washing membranes for three times
with TBST, the protein of interest was visualized using
Super West Pico Enhanced Chemiluminescent (ECL)
substrate or Supersignal West Dura extended duration
ECL substrate kit (Pierce, Rockford, IL). Intensities of
western blotting bands were quantified using the
Kodak 1D software (version 3.6.1, Kodak, Rochester,
NY).
Results and Discussion
RABA Reaction with Peptides
Reductive alkylation is a classical organic reaction that
involves the conversion of a carbonyl group to an amine
[36, 37]. In this study, we explored to use the readilyavailable solvent acetone as the reagent to react with
peptides, which we name as RABA (reductive alkyla-
tion by acetone) reaction. The RABA reaction yields the
addition of an isopropyl group to the N-terminus of a
peptide and the -amino group of Lys residues (see eq
1), producing a 42 Da mass increase for each isopropyl
addition to peptides. Moreover, when deuterium-
enriched acetone (d6-acetone) is used in the reaction, a
mass increase of 48 Da will be produced for each
d6-isopropyl group attached to peptides. The 6 Da mass
split between the d0- and d6-isopropyl modified pep-
tides can minimize the contribution of the naturally
occurring isotopic envelop to a negligible level, provid-
ing an advantage over smaller mass split introduced by
other labeling methods [18, 20, 23]. Therefore, the
RABA approach would provide the benefit of signifi-
cantly less interference from naturally occurring isoto-
pic peaks.
Figure 1 shows the ESI (Figure 1a) and MALDI-TOF
(Figure 1b) mass spectra of a standard peptide angio-
tensin II with and without the RABA reaction. The top
panel is angiotensin II in the control using acetone
without the reducing regent NaBH3CN, in which the
RABA reaction did not occur. A peak at m/z 523.76 in
the ESI mass spectrum represents the doubly charged
ions of angiotensin II and a peak at m/z 534.76 repre-
sents the doubly charged ion of sodium adducts of
angiotensin II (top panel). After 30 min RABA reaction
as described in the Experimental section, a peak at m/z
544.80 represents the doubly charged ion of angiotensin
II with one isopropyl group at the N-terminus (middle
panel). Similarly, the sodium adduct of the angiotensin
II-isopropyl product was detected at m/z 555.79. We did
not detect any di-isopropyl products of angiotensin II,
suggesting that the RABA reaction only produces
mono-isopropyl product to the amine group of the
peptide. The data also demonstrate that the arginine
residue in the peptide does not react with acetone. The
results confirmed the findings of Fretheim et al. al-
though they used sodium borohydride in the alkylation
of peptide with acetone [36].
The ESI mass spectrum of equal quantity of angioten-
sin II with and without the RABA reaction is shown in the
lower panel of Figure 1a. The intensity of the isopropyl-
modified angiotensin II was 1.7-fold stronger com-
pared to that of the unmodified peptide. The isopropyl
group introduced by the RABA reaction increases the
basicity of the peptide, thus improving the ionization
efficiency of the peptide as previously reported [14, 15].
However, the pair of d0- and d6-isopropyl modified
peptides showed no ionization efficiency difference in
this study (see Figure 3c).
SI an
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sin II with and without the RABA reaction and the spectra
are shown in Figure 1b. Consistent with the ESI data, the
reaction between angiotensin II and acetone produces a
mono-isopropyl product of angiotensin II. In addition, the
isopropyl-modified angiotensin II also yielded 1.6-fold
stronger signals than the unmodified angiotensin II.
Time Course of the RABA Reaction with Peptides
We observed that the RABA reaction with peptides
went extremely fast, particularly under the acidic con-
ditions in our experiments. We used the intensities of
the isopropyl product and the native angiotensin II
peaks to calculate the yield of the RABA reaction at
different intervals of reaction time as defined by eq 2.
The cofactor f reflects the different ionization efficien-
cies of intact and isopropyl-modified angiotensin II.
Based on the ESI spectrum in Figure 1a, the f cofactor is
1.7 for angiotensin II.
Yield
Intensitymodified peptide
Intensitymodified peptide  f * Intensityintact peptide
(2)
The reaction yield of the RABA reaction with angioten-
sin II was 93.3% after 3 min reaction, 96% after 10 min,
and reached 99% in 30 min. Therefore, all RABA
reactions with peptides were performed for 30 min in
further experiments unless indicated otherwise.
Sensitivity of the RABA Reaction with Peptides
Since the quantities of proteins/peptides in proteomics
Figure 1. The electrospray (a) and MALDI-TOF
the RABA reaction. The top panels are the spect
mock reaction without the reducing agents. The m
30 min RABA reaction. The lower panels show
the top and middle panels. In the ESI mass sp
Na-adduct (544.80) of angiotensin II were detected
and MALDI-TOF spectra after 30 min RABA react
peptide is higher than the intact peptide in both Estudies may be limited, we tested how much peptidewas required to perform a complete RABA reaction.
When 1.0 pmol myoglobin tryptic peptide was used as
the starting material for the RABA reaction, the concen-
tration of the peptides in the 25 L reaction mixture was
40 fmol/L. The reaction was performed for 30 min and
stopped by vacuum drying. The sample was reconsti-
tuted in 20 L water/0.1% formic acid and one fourth of
the sample (i.e., 5 L aliquot containing 250 fmol
myoglobin tryptic peptides) was subjected to LC-
MS/MS analysis and MASCOT search for isopropyl-
modified peptides. Eleven tryptic peptides were iden-
tified (67% sequence coverage) and all of them were
isopropyl-modified. We further tested the RABA reac-
tion using 200 fmol myoglobin tryptic peptides as
starting material, i.e., 8 fmol/L tryptic peptides in 25
L reaction mixture. One-fourth of the reaction mixture
(i.e., 50 fmol myoglobin tryptic peptides) was subjected
to LC-MS/MS analysis and we detected five isopropyl-
modified tryptic peptides (33% sequence coverage). In
addition, the un-modified tryptic peptides were still not
observed in the extraction ion chromatograph in both
experiments. The results demonstrate that the RABA
reaction with peptides can be achieved stoichiometri-
cally even at the low fmol/L peptide concentration.
Quantitative Analysis Using Peptide RABA
Reaction: Dynamic Range and Reproducibility in
Reverse Labeling
After establishing the specificity, time course and sen-
sitivity of the RABA reaction using acetone, we used
d6-acetone in the RABA reaction in the same fashion as
described above. We observed identical specificity, time
course, and sensitivity of the reaction using d6-acetone.
mass spectra of angiotensin II with and without
un-modified angiotensin II that underwent the
le panels show the spectra of angiotensin II after
pectra of equal volume mix of angiotensin II in
in Figure 1a, both protonated (m/z 523.76) and
unmodified angiotensin II was not detected in ESI
he ionization efficiency of the isopropyl-modified
d MALDI-TOF spectra.(b)
ra of
idd
the s
ectra
. The
ion. TIt is critical to the success of a stable isotope labeling
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bling of the incorporated stable isotopes. In the RABA
reaction with angiotensin II using d6-acetone, the dom-
inant peak in the mass spectrum is the D6-isopropyl
modified peptide, along with a minor peak represent-
ing D5H1-isopropyl modified peptide (spectrum shown
in Supplementary Figure 1 in the supporting materials,
which can be found in the electronic version of this
article). As shown in the figure, the intensity of the
D5H1 peak is 1% of that of the D6-isopropyl modified
peptide. A possible explanation for the D5H1-isopropyl
modified peptide is that a small portion of the enol
isomer of d6-acetone may undergo deuterium to hydro-
gen back exchange in solution. In addition, the d6-
acetone used in this study was 99.9 atom% of deute-
rium, which also helped minimizing the peak of the
D5H1-isopropyl modified peptide. Given the low abun-
dance of the D5H1-isopropyl modified peptide, the
isotope effect in the RABA reaction using d6-acetone is
negligible. Thus, this reaction is suitable for incorporat-
ing stable isotopes to peptides and being utilized for
Figure 2. The linear range of the quantitative a
experimentally determined ratios are plotted ver
ratios determined using ESI mass spectrometry.
using MALDI-TOF mass spectrometry. The forw
were carried out to demonstrate that the RABA
regression of the experimental ratios is shown in
expected ratios.quantitative analysis.We first evaluated the dynamic range of the RABA-
based quantitative analysis. Angiotensin II was diluted
from 50 pmol/L stock solution (in 90% acetonitrile,
0.1% formic acid) to 25, 10 and 5 pmol/L. RABA
reaction with 20 L of 50 pmol/L angiotensin II
solution was performed using d0-acetone. RABA reac-
tion with each 20 L of 50, 25, 10 and 5 pmol/L
angiotensin II solutions was performed using d6-
acetone. Equal volume of the d0- and d6-RABA reaction
was mixed to generate samples with expected ratios of
d0/d6  1:1, 2:1, 5:1 and 10:1, respectively. Similarly,
different quantities of d0- and d6-isopropyl modified
angiotensin II were mixed at reverse ratios at d6/d0 
1:1, 2:1, 5:1, and 10:1, respectively. The samples of the
d0- and d6-isopropyl modified angiotensin II were an-
alyzed by direct infusion ESI-MS. The experimental
ratio of d0- and d6-isopropyl adducts in each sample
was calculated using the intensities of the light and
heavy monoisotopic peaks. All experiments were car-
ried out in triplicates independently.
Figure 2a shows the experimentally determined
ch using the RABA reaction with peptides. The
xpected ratios. Figure 3a and b are experimental
re 3a and d are experimental ratios determined
nd reverse labeling of peptide (d0/d6 and d6/d0)
roach has little isotope scrambling. The linear
panel. The dashed lines are expected lines of thepproa
sus e
Figu
ard a
app
eachd0/d6 ratios versus the expected ratios. Figure 2b shows
mod
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expected ratios. The experimental ratios clearly agree
with the expected ratio in the dynamic range from 1:10
to 10:1. Within this range, the correlation coefficiency
(R2) is 0.999 and 0.998 for Figure 2a and b, respectively.
The relative standard deviation (RSD) of the triplicate
experiments is less than 10% for all data points. Thus,
the quantitative results using RABA reaction can be
faithfully reproducible in reverse labeling, which pro-
vides strong support for the reliability and accuracy of
this stable isotope labeling strategy.
Furthermore, we performed the dynamic range stud-
ies of the quantitative analysis of the above mixtures
using a different type of mass spectrometer, MALDI-
TOF. As shown in Figure 2c and d, the ratios deter-
mined by the peak intensities from the MALDI-TOF
mass spectra consistently agree with the expected ra-
tios. The dynamic range obtained from the MALDI-TOF
data is from 1:20 to 20:1, which is even better than that
obtained from direct infusion ESI-MS. Within this
range, the correlation coefficiency (R2) is 0.999 for both
Figure 2c and d. The relative standard deviation (RSD)
of the triplicate experiments is less than 10% for all data
points. The results again demonstrate that the RABA
reaction can produce reliable quantitative analysis in
both directions of stable isotope labeling. In addition,
this strategy can be used for both ESI and MALDI types
of mass spectrometers.
It is noted that the RABA reaction was indepen-
dently carried out for each individual sample of differ-
ent quantities of peptides and the d0-acetone and d6-
acetone reaction samples were subsequently mixed.
This experimental design, instead of simply mixing the
same reaction products at different ratios, more closely
resembles practical applications in which different
Figure 3. The LC-MS/MS spectra of light and h
The extracted ion chromatography (XIC) of m
corresponding to the doubly charged ions of d0-a
of the light and heavy isotope labeled peptide
peptide eluting 2 s earlier. (b) The XIC of m/z
corresponding to the triply charged ions of d0- an
The heavy isotope labeled peptide eluted 8 s
elution time of the pair of d0- and d6-isopropylquantities of proteins/peptides need to react with thereagents individually before mixing. Thus, the results
presented in this study are more likely to be achieved in
practical applications. It is also noted that the peptides
were analyzed by direct infusion nano-ESI mass spec-
trometry without HPLC enrichment in this set of exper-
iments. The pmol/L concentrations used in the exper-
iments are equivalent to typical practical applications in
which femtomole quantities of peptides are analyzed by
nano-LC-MS/MS.
Quantitative Analysis Using Peptide RABA
Reaction: Application to Tryptic Peptides
After testing the technique with a single peptide angio-
tensin II, we performed the RABA reaction with the
tryptic peptides of myoglobin. Different quantities
myoglobin tryptic peptides in the range of 500 fmol to
10 pmol were subjected to the RABA reaction using d0-
and d6-acetone, respectively. The d0- and d6-isopropyl
modified peptides were mixed and an aliquot of 200
fmol reaction mixture was subjected to nano-LC-
MS/MS analysis. Figure 3 shows representative nano-
LC-MS/MS results of the d0- and d6-isopropyl modified
myoglobin tryptic peptides. Figure 3a is the extracted
ion chromatography (XIC) of m/z 395.76 (solid line) and
m/z 398.78 (dashed line) peaks that represent the doubly
charged ions of mono d0- and d6-isopropyl modified
peptide ALELFR. This pair of mono-isopropyl modified
peptides, which are 6 Da mass units apart, largely
co-eluted in the reverse phase HPLC with a slight
separation of retention time of 2 s. Figure 3b shows
the XIC of m/z 452.60 (solid line) and m/z 456.62 (dashed
line) peaks corresponding to the triply charged ions of d0-
and d12-di-isopropyl modified peptide LFTGHPETLEK.
isotope labeled myoglobin tryptic peptides. (a)
5.76 (solid line) and m/z 398.78 (dashed line)
6-isopropyl modified peptide ALELFR. The pair
gely co-eluted with the heavy isotope labeled
0 (solid line) and m/z 456.62 (dashed line) peaks
2-di-isopropyl modified peptide LFTGHPETLEK.
ier. (c) The average mass spectrum across the
ified peptide ALELFR shown in (a).eavy
/z 39
nd d
s lar
452.6
d d1
earlThis pair of di-isopropyl modified peptides, with an
.43
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lysine residue, is 12 Da apart and largely co-eluted in
the reverse phase HPLC with 8 s separation of reten-
tion time. The results are consistent with the literature
that the HPLC separation of the light and heavy isoto-
pic peptides increases with increasing content of deu-
terium. The mass spectrum was averaged over the peak
elution of the peptide of interest in this study, thus the
separation was less likely to interfere with the quanti-
fication accuracy. However, it increased the complexity
of data analysis, which is yet to be automated. The
HPLC separation of the deuterium labeled peptide can
potentially be minimized by using 13C-labeled reagents
as previously reported [23, 40, 41]. However, the 13C-
labeled acetone (13C3-acetone) can only provide a max-
imal mass split of 3 Da between the light and heavy
isotopic peaks, which is less than ideal. The higher cost
of 13C-labeled acetone would also undermine the cost-
effectiveness of the RABA approach afforded by inex-
pensive d6-acetone. In addition, a computational tool to
automate the data analysis is yet to be developed to plot
extracted ion chromatography of the peptide of interest,
calculate the centroid intensity of the peptide peak
averaged over the elution time, and correct the different
elution time of the light and heavy isotopic peaks. Some
published algorithms such as ASAPRatio [42], Xpress
[17], and MSQuant can also be adapted for quantitative
proteomics data analysis using the RABA approach.
Figure 3c is the average spectrum across the elution
time of the peaks representing d0- and d6-isopropyl
modified peptide ALELFR. The ratio of the d0- and
d6-isopropyl modified peptides was calculated using
the intensities of the corresponding light and heavy
isotopic peaks. The experimental d0/d6 ratio of 0.97:1
agrees well with the expected ratio of 1:1.
Four pairs of d0- and d6-isopropyl modified tryptic
peptides were detected in all samples of different ex-
pected ratios. They were used to calculate the experi-
mental ratios as described above and the results are
Table 1. The experimental ratios of four modified myoglobin tr
Peptides 1:1
LFTGHPETLEK 1.00:1 2
VEADIAGHGQEVLIR 0.99:1 2
ALELFR 0.97:1 2
HGTVVLTALGGILK 0.94:1 2
Average experimental ratio 0.98:1 2
RSD among peptides (%) 2.77 5
Table 2. The experimental ratios of BSA, myoglobin, and cytoch
Protein Pairs of d0- and d6- modified peptides
BSA 13
Myoglobin 10
Cytochrome c 7summarized in Table 1. The experimental ratios of
myoglobin were calculated using the average of four
tryptic peptides and they agreed well with the expected
ratios. The relative standard deviation (RSD) of the four
peptides in each experiment was 10%. The results
demonstrate that the RABA approach can be used for
quantitative analysis of proteins at the femtomole level
in combination of nano-LC.
We subsequently applied this method to quantify
two samples that consisted of three proteins BSA,
myoglobin, and cytochrome c. The ratio of BSA, myo-
globin and cytochrome c in these two samples were 1:1,
2:1 and 10:1, respectively. After the RABA reaction with
d0- and d6-acetone and LC-MS/MS analysis, MASCOT
database search identified 13, 10 and 7 d0- and d6-
isopropyl modified tryptic peptides for BSA, myoglobin
and cytochrome c, respectively. The sequence coverages
were 54%, 88%, and 69% for BSA, myoglobin, and
cytochrome c, respectively. The experimental ratios
were calculated using the intensities of the d0- and
d6-isopropyl modified peptides and the average ratios
of multiple peptides originated from the same protein
are shown in Table 2. The data show that the experi-
mentally determined ratios of three proteins are within
10% of the corresponding expected ratios. The RSD
among the multiple peptides of the same protein was
15% or better.
Furthermore, we tested whether the RABA method
can quantify tryptic peptides in the complex mixture.
We mixed different amounts of BSA, myoglobin, and
cytochrome c with a fixed amount (120 g) of HEK293
cell lysate as described in the Experimental section.
After trypsin digestion, the samples were subjected to
RABA reaction using d0- and d6-acetone and subse-
quently mixed and subjected to nano-LC-MS/MS anal-
ysis. Multiple peptides of BSA, myoglobin, and cyto-
chrome c in the complex background of thousand
peptides derived from HEK293 cell lysate were identi-
fied by MASCOT search. The experimental ratios of
peptides using the RABA approach
Expected ratio
5:1 10:1 20:1
Experimental ratio
4.47:1 11.11:1 26.61:1
5.04:1 13.12:1 25.13:1
5.33:1 13.86:1 29.40:1
4.97:1 13.20:1 31.92:1
4.95:1 12.82:1 28.27:1
7.27 9.28 10.65
e c determined by the RABA reaction with tryptic peptides
pected ratio Average experimental ratio RSD (%)
1:1 0.95:1 12.38
2:1 1.90:1 9.44yptic
2:1
.08:1
.13:1
.31:1
.31:1
.21:1rom
Ex10:1 9.89:1 16.40
, 10.7
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HEK293 cellular proteins (histone H1.4 and actin) were
determined and compared with the expected ratios as
shown in Table 3. The ratios of BSA, myoglobin, and
cytochrome c were determined and were in excellent
agreement with the expected ratios even they were
mixed with HEK293 cell lysate. As a control, the ex-
pected ratio of all HEK293 cellular proteins is constant
at 1:1 since a fixed amount of HEK293 cell lysate was
used in all samples. The experimental ratios of histone
H1.4 and actin were also consistent with the expected
ratio in all experiments. The results demonstrate that
the RABA method can be reliably applied to quantify
proteins in a complex mixture.
It is particularly challenging to quantify low abun-
dance proteins in a complex system. It is noted that the
sensitivity of identifying and quantifying low abun-
dance proteins using stable isotope labeling and LC-
MS/MS approach relies on at least three factors: (1)
efficient isotope labeling reaction, (2) efficient LC sepa-
ration, and (3) accuracy and sensitivity of mass spec-
trometry. In this paper introducing RABA approach as
a novel stable isotope labeling strategy, we have fo-
cused on demonstrating the efficiency of the RABA
reaction. However, it is critical to optimize the LC-
MS/MS platform available in individual laboratory to
achieve accurate quantification of greater number of
proteins including those with low abundance.
Application of the RABA Method for Quantitative
Analysis of Proteins in Transgenic Mouse Models
of Amyotrophic Lateral Sclerosis
We applied the RABA reaction with tryptic peptides to
quantify proteins in mouse spinal cord homogenates
from transgenic mouse models of Amyotrophic Lateral
Sclerosis (ALS). The transgenic mice used in the study
overexpress either wild-type (WT) or G93A mutant
human copper-zinc-superoxide dismutase (SOD1) and
are widely used as animal models of ALS [39, 43]. We
identified 201 unique proteins (at least two unique
peptides for each protein) using LC-MS/MS analysis of
the tryptic digestion of spinal cord homogenates and
quantified them using the RABA approach described
above (Zhai et al., unpublished data). In this method
Table 3. The experimental ratios of BSA, myoglobin, and cytoch
RABA approach
Sample Expected ratio
Ex
Target p
BSA Myog
B:A 1:1 0.93 (6, 5.16) 0.95 (6
C:A 2:1 1.93 (5, 9.84) 2.12 (5
D:A 5:1 5.50 (5, 16.94) 5.50 (4development paper, we hereby present the quantitativeresults obtained with selected proteins as summarized
in Table 4. In particular, we focus on the quantification
of two proteins with high sequence homology in the
transgenic mouse models: human and mouse SOD1
(Figure 4). In addition, we validated the quantitative
results using the Western blotting technique as shown
in Figure 5.
Figure 4a shows the sequence alignment of the
transgenic human SOD1 and the endogenous mouse
SOD1. Seven tryptic peptides of human SOD1 were
identified, four of which are unique to human SOD1
(i.e., not present in mouse SOD1). The four unique
human SOD1 peptides are shown in red in Figure 4a.
Four peptides of mouse SOD1 were identified, one of
which is unique to mouse SOD1 as shown in green in
Figure 4a. Three tryptic peptides that are common to
human and mouse SOD1 are shown in yellow. The
unique human SOD1 peptides were used to determine
the ratio of the transgenic protein in two different
transgenic mouse lines. Figure 4b shows the average
mass spectrum of all peptides eluted during 65.3 to 66.1
min and the m/z 351.70 peak is isopropyl modified
peptide ADDLGK that is unique to human SOD1. The
zoomed mass spectrum of the d0- and d12-di-isopropyl
modified forms of the peptide (doubly charged, m/z
351.70 and m/z 357.74) is shown in Figure 4c. The d0-
and d12-di-isopropyl modified peptides were derived
e c and other proteins in HEK293 cell lysate determined by the
ental ratio (no. of peptides, RSD%)
ins
Background proteins (expected
ratio is 1:1)
Cytochrome c Histone H1.4 Actin
) 0.91 (2, N/A) 0.98 (4, 8.16) 1.03 (2, N/A)
2) 1.9 (3, 17.89) 0.93 (3, 10.54) 1.20 (2, N/A)
5) 5.37 (1, N/A) 0.91 (4, 10.33) 0.99 (2, N/A)
Table 4. Quantification of transgenic human SOD1,
endogenous mouse SOD1 and actin in wild-type (WT) and
G93A mutant human SOD1 transgenic mouse models
Protein Unique Peptide
Experimental
ratio
(WT/G93A)
Average
(RSD%)
hSOD1 ADDLGK 1.92 2.15 (13.95)
VWGSIK 2.10
ESNGPVK 2.59
GDGPVQGIINFEQK 2.00
mSOD1 VISLSGEHSIIGR 1.05 1.05 (N/A)
Actin GILTLK 1.19 1.00 (12.70)
IIAPPER 0.85
AGFAGDDAPR 1.00
AVFPSIVGRPR 0.83
DSYVGDEAQSK 1.03
IWHHTFYNELR 1.09rom
perim
rote
lobin
, 5.79
, 11.3VAPEEHPVLLTEAPLNPK 1.00
ide V
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SOD1 transgenic mouse models, respectively. The ratio
of these two isotopic peaks was calculated to be 1.92.
The ratios of the four human SOD1 unique peptides
were summarized in Table 4. The average ratio of the
four human SOD1 unique peptides was 2.15 with RSD
of 13.95%.
Figure 4d shows the mass spectrum of the d0- and
d6-isopropyl modified mouse SOD1 unique peptide
VISLSGEHSIIGR (triply charged, m/z 470.61 and 472.62).
The ratio of the isotopic peaks was 1.05. Since this is the
sole unique mouse SOD1 peptide identified, the ratio of
endogenous mouse SOD1 between the two transgenic
models was determined as 1.05. The result was consis-
tent with the expectation that the endogenous SOD1
levels are constant in different transgenic lines. In
addition, the ratio of the housekeeping protein actin
between the two transgenic mouse models was calcu-
lated using seven tryptic peptides and the average ratio
was 1.00 with RSD 12.70% (Table 4).
Furthermore, we validated the quantitative results
obtained from the RABA method using the Western
blotting technique. Figure 5 shows the Western blot of
human SOD1 and it is evident that its expression level
in WT SOD1 transgenic mouse was approximately two
Figure 4. Quantitative analysis of mouse sp
Sequence alignment of the transgene human SO
human SOD1 peptides identified in LC-MS/MS
is underlined. The peptides common to both hu
The average mass spectrum of the peptides elut
including the human SOD1 unique peptide ADD
spectrum of d0- and d12-di-isopropyl modified p
spectrum of d0- and d6-isopropyl modified pepttimes higher than in the G93A mutant SOD1 transgenicmouse. The same film was exposed longer to detect the
endogenous mouse SOD1 that was at a significantly
lower level compared with the transgene human SOD1.
The endogenous mouse SOD1 levels were approxi-
mately the same in the two transgenic mouse lines. The
Western blotting of actin also showed unchanged ex-
pression between the two transgenic lines. The intensi-
ties of the human SOD1 band in WT and mutant SOD1
transgenic mice were quantified using the Kodak 1D
software (version 3.6.1). After normalization with actin,
the human SOD1 in WT SOD1 transgenic mouse was
1.89 times of that in the G93A mutant SOD1 transgenic
mouse, which was consistent with the quantification
result obtained using the RABA approach (average of
2.15 with RSD 13.95%).
The above results demonstrate that the RABA
method can be successfully applied to quantify proteins
in complex samples. In addition, the RABA method can
distinguish highly homologous proteins, such as hu-
man and mouse SOD1 in this study and can quantify
them individually. The quantitative results obtained
with this method are reliable and can be validated by
independent techniques, such as Western blotting. The
quantification of both human and mouse SOD1, whose
expression levels are drastically different as evidenced
crod proteins using the RABA approach. (a)
and the endogenous mouse SOD1. The unique
ysis are bold. The unique mouse SOD1 peptide
and mouse SOD1 are bold and underlined. (b)
ring 65.3–66.1 min in the LC-MS/MS analysis,
at m/z 351.70. (c) The zoomed view of the mass
e ADDLGK. (d) The zoomed view of the mass
ISLSGEHSIIGR that is unique to mouse SOD1.inal
D1
anal
man
ed du
GLK
eptidby Western blot in Figure 5, supports that the RABA
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complex mixture.
Conclusions
We have developed a novel stable isotope labeling
strategy for quantitative proteomic analysis. The RABA
reaction can react with the primary amine groups at the
N-terminus and lysine residues stoichiometrically
within a short period of time. When unlabeled (d0) and
deuterated (d6) acetone are used, the reaction generates
a pair of light and heavy isotope labeled peptides with
mass separation of 6 Da each reactive amine group in
the peptide. The strategy is well suited for quantitative
proteomic analysis because the 6 Da mass separation
can avoid the naturally occurring isotope envelop and
the light and heavy isotope pairs largely co-elute in
reverse phase HPLC. The RABA reaction has been
utilized to label peptides. The utility of the approach
was demonstrated using standard peptides, tryptic
peptides from proteins as well as human cell lysate and
transgenic mouse tissue homogenate. The results ob-
tained in all experiments supported that the RABA
method can be used to achieve reliable quantification of
proteins levels at the femtomole range in complex
samples. The advantages of the RABA approach in-
clude the relative simplicity of the reaction, the high
yield to produce leveled peptides in a short period of
time, and 6 Da mass separation between the light and
heavy isotope labeled peptides. In addition, the ready
availability of the inexpensive reagents makes this
approach an appealing alternative for binary quantita-
tive proteomic analysis. Similar approaches using ke-
Figure 5. Western blotting validation of quantitative results
obtained by the RABA approach. The level of human SOD1 in WT
SOD1 transgenic mouse was approximately two time of that in
G93A SOD1 transgenic mouse. The prolonged exposure detected
mouse SOD1 and showed approximately equal expression be-
tweenWT and SOD1 transgenic mouse models. The housekeeping
protein actin was also unchanged between the two transgenic
mouse models. All results are consistent with the quantitative
analysis using the RABA approach and mass spectrometry.tones with long alkyl chains conceptually can be uti-lized for multiplex quantitative analysis, which is cur-
rently being investigated in our laboratory.
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